header-image

Process Validation in the light of the revised Annex 15 and FDA Requirements
Im Auftrag der ECA Academy

16-17 October 2019, Berlin, Germany

Seminar-Nr. 16934

You can find all other dates of this seminar in this overview.

Sprecher

Dr Christopher Burgess, Chair of ECA´s Analytical Quality Control Group, UK

Klaus Eichmüller, EU Inspector, Germany

Dr Line Lundsberg-Nielsen, NNE, UK

Gert Moelgaard, Past Chairman of ISPE, Head of ECA´s Validation Group, Denmark

Dr Thomas Schneppe, Bayer Bitterfeld GmbH, Germany

Zielsetzung

With publication of the Guidance for Industry “Process Validation: General Principles and Practices” 2011, the FDA requires a new direction. Validation is now a „Life Cycle Process” with 3 stages:

  • Process Design
  • Process Qualification
  • Continued Process Verification
The focus is on process knowledge and process understanding. Both should be a result of development and verified in routine production. The “magic” 3 batches are not mentioned any more. What is very important nowadays is the term „scientific sound“, and explicit statistics are mentioned. Six Sigma elements (e.g. Design of Experiments, DoE) are also mentioned directly or indirectly. There will be a new stage in routine production called „continued process verification“.
With the revision of Annex 15 EU GMP Guide the EU is going in the same direction: Validation is a lifecycle with pharmaceutical development als basis and also a stage 3 is mentioned, called Ongoing Process Verification. In Europe 3 validation approaches are now possible – traditional, continuous and hybrid.

  • How can the new requirements be achieved?
  • How fit the FDA requirements into European guidelines and vice versa? , How can process knowledge and process understanding be demonstrated on the basis of development studies?
  • When is a process valid now?
  • Which parameters can be used for knowledge and understanding studies?
  • How can „continued/ongoing process verification” be realised?
  • How can statistics help?
These questions are discussed, and the possibilities for implementation are covered.

Hintergrund

Since 1987 the FDA Guideline on Process Validation has been the basis for qualification and validation. Within the new FDA programme “Pharmaceutical cGMPs for the 21st Century” there was an announcement for a revision of the guideline. A new FDA Policy Guide of 2004 gives some hints to the new validation approach. In November 2008 the new “Guidance for Industry Process Validation: General Principles and Practices” was published as a draft and came into operation in January 2011. That is now FDA’s „current thinking“. Chapter 1 of the EU GMP Guide gives hints for more emphasises on process capabilities and varieties within process validation also in Europe. EMA´s Process Validation Guidance and also the revised Annex 15 which come into force on 1 October 2015 takes a life cycle approach to process validation.

Zielgruppe

The addressees of the event are qualified staff charged with or responsible for validation activities, such as commissioners for validation, heads of quality assurance, department heads, etc.

It also addresses members of validation teams (e.g. engineers, chemists, pharmacists, microbiologists) as well as representatives of the plant engineering industry and consultants.

Free

1) Inspectors Aide memoire on Process Validation: The Guide is developed by the Central Authority of the Länder for Health Protection with regard to Medicinal Products and Medical Devices (ZLG) – English translation. This document covers the whole spectrum of process validation regarding the Annex 15 revision The Aide Memoire is really helpful as a tool to prepare for an Authority’s GMP Inspection.

2) Free Download: ECA´s Modern Qualification Good Practice Guide

Programm

FDA Thinking

  • How the concept of Process Validation is about to change
  • Ongoing changes in the Quality Management philosophy
  • Real-life examples
The current EU Approach on Process Validation
  • Process validation in EU guidelines
  • What has changed: Revision of Chapter 1 EU GMP Guide - EMA´s Guidance Process Validation - Annex 15 revision
  • Excursion QbD
  • Excursion Legacy Products
  • The future of process validation
Background and Environment of Process Validation – Industry view
  • Process Validation in guidelines – history
  • The FDA Process Validation Guidance –an overview
  • European perspective: Annex 15 revision
Case Study Process Validation
  • Role of SOP in the company QM System
  • How to deal with the established 3 batch approach?
  • Key aspects (Preconditions, Stages 1-3, Review)
  • Further deliverables from the data and link to other company SOPs
Basics on Statistics
  • An overview about statistical aspects
  • What statistics do you need for modern Process Validation?
Process Design
  • Quality by Design and how it is an enabler for Process Design
Systems and Tools for gaining Process Understanding and establishing the appropriate Control Strategy (I)
  • Quality Risk Management
  • Process Analytical Technology
  • Design of Experiments (including a practical factorial design for establishing the design space or the operating ranges for the process)
  • How the process design is reflected in the control strategy
  • Applying control strategy for stage 2, process qualification and process validation
Performance Qualification Approach
  • Design & qualification of facility, utilities & equipment
  • Performance qualification approach
  • Performance qualification protocol
  • Documenting the quality baseline
Continued/Ongoing Process Verification
  • Process mapping &critical process variables
  • Process data collection and collation
  • Trend analysis & Statistical Process Control
  • Deviation management & CAPA
  • Change management
  • Management’s role in Process Validation
Workshop DoE
The delegates examine a process flow diagram and generate an Ishikawa diagram to identify critical elements.

PPQ Workshop
The delegates make a statistical evaluation of validation data (e.g. trend analysis, Cpk).

Continued/Ongoing Process Verification Workshop
The delegates make a High Level Risk Assessment to analyze where they are going to focus in process verification.

Dieses Seminar/Webinar kann nicht gebucht werden. Alternative Termine für dieses Seminar/Webinar und ähnliche Veranstaltungen finden Sie in der Übersicht nach Thema..

Für viele Seminare und Webinare gibt es auch Aufzeichnungen, die Sie jederzeit bestellen und anschauen können. Diese Aufzeichnungen finden Sie in einer themensortierten Liste.

Oder senden Sie uns Ihre Anfrage einfach über das folgende Kontaktformular.

* auch unkompliziert per Kreditkarte bezahlbar
American Express Visa Mastercard

icon
Weitere Termine vor Ort
Weitere Termine vor Ort nicht verfügbar
icon
Weitere Termine online
Weitere Termine online nicht verfügbar
icon
Aufzeichnung nicht verfügbar

Haben Sie noch Fragen?

Wir stehen Ihnen für weitere Auskünfte gerne zur Verfügung.
Tel.: +49 6221 84 44 0
E-Mail: info@concept-heidelberg.de

Frau mit Headset

Zurück

Teilnehmerstimmen - das sagen andere über unsere Seminare:

Guter, breit gefächerter Überblick mit interessanten Verknüpfungen zur Praxis,
welche die Theorie super veranschaulicht.”
Marina Kicoranovic, Labor Hartmann GmbH
GMP/Basis-Einstiegsschulung (B 14), September 2023

Die Referenten waren sehr gut! Sie haben sehr klar gesprochen, nur sehr wenige englische Begriffe
verwendet (super) und waren sehr praxisbezogen.”
Astrid Gießler, Regierungspräsidium Karlsruhe
Live Online Seminar - Basiskurs Computervalidierung & Datenintegrität im GxP Umfeld (B 3), Juni 2023

Sehr guter Bezug zur Schulung für einen GMP-Anfänger. Habe mich sehr gut abgeholt gefühlt.”
Dr. Harald Werner, Infraserv GmbH & Co. Höchst KG
GMP-Basisschulung (B 1), Juni 2023

NEWSLETTER

Bleiben Sie informiert mit dem GMP Newsletter von Concept Heidelberg!

GMP Newsletter

Concept Heidelberg bietet verschieden GMP Newsletter die Sie auf Ihren Bedarf hin zusammenstellen können.

Hier können Sie sich kostenfrei registrieren.

Kontakt

Kontaktieren Sie uns

Haben Sie Fragen?

Concept Heidelberg GmbH
Rischerstraße 8
69123 Heidelberg

Tel. :+49622184440
Fax : +49 6221 84 44 84
E-Mail: info@concept-heidelberg.de

zum Kontaktformular